Today's Date
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
(
)
ITN Protocol #:
ITN022ST
Branded Name:
ClinicalTrials.Gov ID:
NCT00183248Treatment Protocol #:
Therapeutic Area:
Transplantation
Current Status:
Complete
Summary:
Pilot Study Using Donor Stem Cells and Campath-1H to Induce Renal Transplant Tolerance
Clinical Operations Manager
ITN Biologist
NIAID Project Manager
Rho Data Manager
Rho Scientist
Study Personnel:
